{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:43:06Z","timestamp":1768876986264,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003354","name":"Garnett Passe and Rodney Williams Memorial Foundation","doi-asserted-by":"publisher","award":["Academic Surgeon Scientist Scholarship"],"award-info":[{"award-number":["Academic Surgeon Scientist Scholarship"]}],"id":[{"id":"10.13039\/501100003354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10585-019-09961-6","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:37:34Z","timestamp":1552682254000},"page":"291-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Circulating microRNAs in head and neck cancer: a scoping review of methods"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4535-9282","authenticated-orcid":false,"given":"Nuwan","family":"Dharmawardana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eng Hooi","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charmaine","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"issue":"9","key":"9961_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1634\/theoncologist.2009-0289","volume":"15","author":"D Pulte","year":"2010","unstructured":"Pulte D, Brenner H (2010) Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 15(9):994\u20131001","journal-title":"Oncologist"},{"issue":"3","key":"9961_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.oraloncology.2013.12.008","volume":"50","author":"H Polanska","year":"2014","unstructured":"Polanska H et al (2014) Clinical significance of head and neck squamous cell cancer biomarkers. Oral oncology 50(3):168\u2013177","journal-title":"Oral oncology"},{"issue":"9","key":"9961_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ejca.2012.03.014","volume":"48","author":"M Nygard","year":"2012","unstructured":"Nygard M et al (2012) Population-base evidence of increased survival in human papillomavirus-related head and neck cancer. Eur J Cancer 48(9):1341\u20131346","journal-title":"Eur J Cancer"},{"key":"9961_CR4","doi-asserted-by":"publisher","first-page":"731479","DOI":"10.1155\/2015\/731479","volume":"2015","author":"P Tiberio","year":"2015","unstructured":"Tiberio P et al (2015) Challenges in using circulating miRNAs as cancer biomarkers. BioMed Res Int 2015:731479","journal-title":"BioMed Res Int"},{"issue":"5","key":"9961_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843\u2013854","journal-title":"Cell"},{"issue":"6772","key":"9961_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/35002607","volume":"403","author":"BJ Reinhart","year":"2000","unstructured":"Reinhart BJ et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901\u2013906","journal-title":"Nature"},{"issue":"2","key":"9961_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"key":"9961_CR8","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1038\/onc.2009.353","volume":"27","author":"P Trang","year":"2009","unstructured":"Trang P, Weidhaas JB, Slack FJ (2009) MicroRNAs as potential cancer therapeutics. Oncogene 27:S52","journal-title":"Oncogene"},{"issue":"30","key":"9961_CR9","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513\u201310518","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9961_CR10","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1038\/emm.2017.288","volume":"50","author":"D Poel","year":"2018","unstructured":"Poel D et al (2018) Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer. Exp Mol Med 50(3):e454","journal-title":"Exp Mol Med"},{"issue":"1","key":"9961_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","volume":"18","author":"Z Munn","year":"2018","unstructured":"Munn Z et al (2018) Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol 18(1):143","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"9961_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bjorl.2016.03.013","volume":"83","author":"O Cinpolat","year":"2017","unstructured":"Cinpolat O et al (2017) Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: a prospective, case-control study. Braz J Otorhinolaryngol 83(3):276\u2013284","journal-title":"Braz J Otorhinolaryngol"},{"issue":"1","key":"9961_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3892\/etm_00000035","volume":"1","author":"JA Ricieri Brito","year":"2010","unstructured":"Ricieri Brito JA et al (2010) Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging. Exp Ther Med 1(1):217\u2013221","journal-title":"Exp Ther Med"},{"issue":"24","key":"9961_CR14","first-page":"5137","volume":"20","author":"Y Xu","year":"2016","unstructured":"Xu Y et al (2016) Expression of serum microRNA-378 and its clinical significance in laryngeal squamous cell carcinoma. Eur Rev Med Pharmacol Sci 20(24):5137\u20135142","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9961_CR15","first-page":"7329195","volume":"2018","author":"X Xu","year":"2018","unstructured":"Xu X et al (2018) Dynamic changes in plasma microRNAs have potential predictive values in monitoring recurrence and metastasis of nasopharyngeal carcinoma. BioMed Res Int 2018:7329195","journal-title":"BioMed Res Int"},{"issue":"5","key":"9961_CR16","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.18632\/oncotarget.14143","volume":"8","author":"Y Yan","year":"2017","unstructured":"Yan Y et al (2017) Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. Oncotarget 8(5):8206\u20138214","journal-title":"Oncotarget"},{"key":"9961_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fonc.2017.00191","volume":"7","author":"G Rabinowits","year":"2017","unstructured":"Rabinowits G et al (2017) Comparative analysis of microRNA expression among benign and malignant tongue tissue and plasma of patients with tongue cancer. Front Oncol 7:191","journal-title":"Front Oncol"},{"issue":"1","key":"9961_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/bjc.2015.111","volume":"113","author":"I Summerer","year":"2015","unstructured":"Summerer I et al (2015) Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br J Cancer 113(1):76\u201382","journal-title":"Br J Cancer"},{"issue":"22","key":"9961_CR19","doi-asserted-by":"publisher","first-page":"19246","DOI":"10.18632\/oncotarget.4266","volume":"6","author":"BV Martinez","year":"2015","unstructured":"Martinez BV et al (2015) Circulating small non coding RNA signature in head and neck squamous cell carcinoma. Oncotarget 6(22):19246\u201319263","journal-title":"Oncotarget"},{"issue":"9","key":"9961_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3109\/00016489.2016.1165862","volume":"136","author":"L Wei","year":"2016","unstructured":"Wei L, Mao M, Liu H (2016) Droplet digital PCR and qRT-PCR to detect circulating miR-21 in laryngeal squamous cell carcinoma and pre-malignant laryngeal lesions. Acta Oto-laryngologica 136(9):923\u2013932","journal-title":"Acta Oto-laryngologica"},{"key":"9961_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1748-717X-8-296","volume":"8","author":"I Summerer","year":"2013","unstructured":"Summerer I et al (2013) Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol 8:296","journal-title":"Radiat Oncol"},{"key":"9961_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1743-422X-10-119","volume":"10","author":"C Gourzones","year":"2013","unstructured":"Gourzones C et al (2013) Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients\u2014evidence of non-exosomal transport. Virol J 10:119","journal-title":"Virol J"},{"issue":"6","key":"9961_CR23","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s13277-012-0454-8","volume":"33","author":"CM Hsu","year":"2012","unstructured":"Hsu CM et al (2012) Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 33(6):1933\u20131942","journal-title":"Tumour Biol"},{"key":"9961_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1743-422X-7-271","volume":"7","author":"C Gourzones","year":"2010","unstructured":"Gourzones C et al (2010) Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J 7:271","journal-title":"Virol J"},{"issue":"6","key":"9961_CR25","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.3892\/or.2017.5639","volume":"37","author":"J Ries","year":"2017","unstructured":"Ries J et al (2017) Prognostic significance of altered miRNA expression in whole blood of OSCC patients. Oncol Rep 37(6):3467\u20133474","journal-title":"Oncol Rep"},{"issue":"4","key":"9961_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00432-015-2087-y","volume":"142","author":"C Lerner","year":"2016","unstructured":"Lerner C et al (2016) Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration. J Cancer Res Clin Oncol 142(4):757\u2013766","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"9961_CR27","first-page":"851","volume":"28","author":"J Ries","year":"2014","unstructured":"Ries J et al (2014) Alterations in miRNA expression patterns in whole blood of OSCC patients. In vivo 28(5):851\u2013861","journal-title":"In vivo"},{"issue":"3","key":"9961_CR28","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3892\/or.2014.2983","volume":"31","author":"J Ries","year":"2014","unstructured":"Ries J et al (2014) miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood. Oncol Rep 31(3):1429\u20131436","journal-title":"Oncol Rep"},{"issue":"2","key":"9961_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/1354750X.2017.1289241","volume":"23","author":"G Sun","year":"2018","unstructured":"Sun G et al (2018) miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma. Biomarkers 23(2):137\u2013141","journal-title":"Biomarkers"},{"issue":"1","key":"9961_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41598-017-18945-z","volume":"8","author":"A Schneider","year":"2018","unstructured":"Schneider A et al (2018) Tissue and serum microRNA profile of oral squamous cell carcinoma patients. Sci Rep 8(1):675","journal-title":"Sci Rep"},{"issue":"1","key":"9961_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13277-015-3514-z","volume":"37","author":"H Xu","year":"2016","unstructured":"Xu H et al (2016) Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma. Tumour Biol 37(1):447\u2013453","journal-title":"Tumour Biol"},{"key":"9961_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.12659\/MSM.895683","volume":"22","author":"L Sun","year":"2016","unstructured":"Sun L et al (2016) Association of decreased expression of serum miR-9 with poor prognosis of oral squamous cell carcinoma patients. Med Sci Monit 22:289\u2013294","journal-title":"Med Sci Monit"},{"issue":"8","key":"9961_CR33","first-page":"13296","volume":"8","author":"Q Yu","year":"2015","unstructured":"Yu Q et al (2015) Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinoma. Int J Clin Exp Med 8(8):13296\u201313302","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"9961_CR34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1080\/15384047.2015.1045692","volume":"16","author":"B Hou","year":"2015","unstructured":"Hou B et al (2015) Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma. Cancer Biol Ther 16(7):1042\u20131046","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"9961_CR35","doi-asserted-by":"publisher","first-page":"e0159693","DOI":"10.1371\/journal.pone.0159693","volume":"11","author":"H Tachibana","year":"2016","unstructured":"Tachibana H et al (2016) Circulating miR-223 in oral cancer: its potential as a novel diagnostic biomarker and therapeutic target. PLoS ONE 11(7):e0159693","journal-title":"PLoS ONE"},{"issue":"6","key":"9961_CR36","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/ijc.28468","volume":"134","author":"N Liu","year":"2014","unstructured":"Liu N et al (2014) A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int J Cancer 134(6):1359\u20131368","journal-title":"Int J Cancer"},{"issue":"10","key":"9961_CR37","doi-asserted-by":"publisher","first-page":"e46367","DOI":"10.1371\/journal.pone.0046367","volume":"7","author":"X Zeng","year":"2012","unstructured":"Zeng X et al (2012) Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS ONE 7(10):e46367","journal-title":"PLoS ONE"},{"issue":"2","key":"9961_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/cam4.17","volume":"1","author":"SA Maclellan","year":"2012","unstructured":"Maclellan SA et al (2012) Differential expression of miRNAs in the serum of patients with high-risk oral lesions. Cancer Med 1(2):268\u2013274","journal-title":"Cancer Med"},{"key":"9961_CR39","doi-asserted-by":"publisher","first-page":"7648215","DOI":"10.1155\/2016\/7648215","volume":"2016","author":"S Liang","year":"2016","unstructured":"Liang S et al (2016) Increased serum level of MicroRNA-663 is correlated with poor prognosis of patients with nasopharyngeal carcinoma. Dis Markers 2016:7648215","journal-title":"Dis Markers"},{"key":"9961_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1479-5876-12-3","volume":"12","author":"JL Plieskatt","year":"2014","unstructured":"Plieskatt JL et al (2014) Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma. J Trans Med 12:3","journal-title":"J Trans Med"},{"issue":"9","key":"9961_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1373\/clinchem.2015.241190","volume":"61","author":"Y He","year":"2015","unstructured":"He Y et al (2015) Current state of circulating microRNAs as cancer biomarkers. Clin Chem 61(9):1138\u20131155","journal-title":"Clin Chem"},{"key":"9961_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jnutbio.2018.03.010","volume":"57","author":"S Lopez","year":"2018","unstructured":"Lopez S et al (2018) A microRNA expression signature of the postprandial state in response to a high-saturated-fat challenge. J Nutr Biochem 57:45\u201355","journal-title":"J Nutr Biochem"},{"issue":"8","key":"9961_CR43","doi-asserted-by":"publisher","first-page":"11057","DOI":"10.1007\/s13277-016-4981-6","volume":"37","author":"S Zhang","year":"2016","unstructured":"Zhang S et al (2016) Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus. Tumour Biol 37(8):11057\u201311063","journal-title":"Tumour Biol"},{"issue":"6","key":"9961_CR44","first-page":"688","volume":"35","author":"Z Su","year":"2014","unstructured":"Su Z, Hou XK, Wen QP (2014) Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression. Eur J Gynaecol Oncol 35(6):688\u2013691","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"9961_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/cbin.10034","volume":"37","author":"J Zhang","year":"2013","unstructured":"Zhang J et al (2013) Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression. Cell Biol Int 37(3):227\u2013232","journal-title":"Cell Biol Int"},{"issue":"5","key":"9961_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2220\/biomedres.33.255","volume":"33","author":"S Tanaka","year":"2012","unstructured":"Tanaka S et al (2012) Changes in microRNA expression in rat lungs caused by sevoflurane anesthesia: a TaqMan(R) low-density array study. Biomed Res 33(5):255\u2013263","journal-title":"Biomed Res"},{"issue":"6","key":"9961_CR47","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3892\/ijmm.2016.2797","volume":"38","author":"W Yi","year":"2016","unstructured":"Yi W et al (2016) Sevoflurane inhibits the migration and invasion of glioma cells by upregulating microRNA-637. Int J Mol Med 38(6):1857\u20131863","journal-title":"Int J Mol Med"},{"issue":"2","key":"9961_CR48","doi-asserted-by":"publisher","first-page":"e0167969","DOI":"10.1371\/journal.pone.0167969","volume":"12","author":"C Glinge","year":"2017","unstructured":"Glinge C et al (2017) Stability of circulating blood-based microRNAs\u2014pre-analytic methodological considerations. PLoS ONE 12(2):e0167969","journal-title":"PLoS ONE"},{"issue":"12","key":"9961_CR49","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1158\/1055-9965.EPI-14-0550","volume":"23","author":"H Zhao","year":"2014","unstructured":"Zhao H et al (2014) Effects of preanalytic variables on circulating microRNAs in whole blood. Cancer Epidemiol Biomarkers Prev 23(12):2643\u20132648","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"9961_CR50","doi-asserted-by":"publisher","first-page":"e0201069","DOI":"10.1371\/journal.pone.0201069","volume":"13","author":"HG Binderup","year":"2018","unstructured":"Binderup HG et al (2018) Quantification of microRNA levels in plasma\u2014impact of preanalytical and analytical conditions. PLoS ONE 13(7):e0201069","journal-title":"PLoS ONE"},{"issue":"9","key":"9961_CR51","doi-asserted-by":"publisher","first-page":"e24145","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner MB et al (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE 6(9):e24145","journal-title":"PLoS ONE"},{"issue":"5","key":"9961_CR52","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1128\/JCM.02408-16","volume":"55","author":"K Jorge","year":"2017","unstructured":"Jorge K et al (2017) Characterization of microRNA expression profiles and identification of potential biomarkers in leprosy. J Clin Microbiol 55(5):1516\u20131525","journal-title":"J Clin Microbiol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-019-09961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-019-09961-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-019-09961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:24:10Z","timestamp":1584059050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-019-09961-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9961"],"URL":"https:\/\/doi.org\/10.1007\/s10585-019-09961-6","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"assertion":[{"value":"2 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}